Alan Kersey has been engaged in sensor technology research and commercialization for more than the past 3 decades. His research work began in 1981 at the University of Kent, which was followed by a 14 year tenure at the Naval Research Laboratory (NRL) in Washington DC. At NRL his focus on advanced fiber optic based sensing concepts, led to some of the seminal research on Bragg grating sensor systems.
In 1997, Alan joined a start-up, CiDRA, as it’s founding Chief Technology Officer, to develop fiber Bragg grating sensors for the Oil & Gas industry. He served on CiDRA's board from 2001 to 2003. From 2003 to 2005, he was CEO of CyVera, a spin-out from CiDRA which developed a genetic analysis/assay platform – BeadXpress which was based on Bragg grating technology as an encoding mechanism for particles in a bio-assay system. Prior to the commercial launch of the platform, CyVera was acquired by the leading genetic sequencing company, Illumina. Following this acquisition, Alan was VP & General Manager of Illumina’s division based in Cambridge, UK. Most recently, he re-joined CiDRA in an M&A role, to bring new sensor technologies to the suite the company has already developed & successfully deployed in industrial applications.
Currently Alan serves as a Non-Executive Director on the Boards of Industrial Tomography Systems (ITS) in the UK, and ReadyDock in the US. He is a member of the Technical Advisory Boards of Insight Photonics, and Taff Optical. He is also currently engaged in the formation of several new biotech start-ups under a new entity, CyOmics LLC, and a venture capital fund, Cycle Venture Partners.
Alan holds a B.Sc in Physics & Electronics at the University of Warwick, a Ph.D. from the University of Leeds, and is a Fellow of The Optical Society. He has published extensively in journal and conference forums, and holds over 100 patents in optical sensing and instrumentation.